nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—Abnormal faeces—Metformin—polycystic ovary syndrome	0.0228	0.109	CcSEcCtD
Bexarotene—CYP2C9—urine—polycystic ovary syndrome	0.0165	0.114	CbGeAlD
Bexarotene—RXRG—pituitary gland—polycystic ovary syndrome	0.0128	0.0887	CbGeAlD
Bexarotene—RXRG—adipose tissue—polycystic ovary syndrome	0.0127	0.0883	CbGeAlD
Bexarotene—CYP3A4—urine—polycystic ovary syndrome	0.0126	0.0872	CbGeAlD
Bexarotene—RXRA—female gonad—polycystic ovary syndrome	0.0121	0.0841	CbGeAlD
Bexarotene—RXRG—adrenal gland—polycystic ovary syndrome	0.0114	0.0792	CbGeAlD
Bexarotene—RXRA—endocrine gland—polycystic ovary syndrome	0.0113	0.0782	CbGeAlD
Bexarotene—RXRB—adrenal gland—polycystic ovary syndrome	0.0107	0.0745	CbGeAlD
Bexarotene—RXRB—female gonad—polycystic ovary syndrome	0.01	0.0694	CbGeAlD
Bexarotene—RXRB—vagina—polycystic ovary syndrome	0.00994	0.069	CbGeAlD
Bexarotene—RXRG—endocrine gland—polycystic ovary syndrome	0.00989	0.0687	CbGeAlD
Bexarotene—RXRB—endocrine gland—polycystic ovary syndrome	0.0093	0.0646	CbGeAlD
Bexarotene—Blood disorder—Metformin—polycystic ovary syndrome	0.00782	0.0373	CcSEcCtD
Bexarotene—Neuropathy—Metformin—polycystic ovary syndrome	0.00613	0.0293	CcSEcCtD
Bexarotene—Ear pain—Metformin—polycystic ovary syndrome	0.00555	0.0265	CcSEcCtD
Bexarotene—Renal impairment—Metformin—polycystic ovary syndrome	0.00498	0.0238	CcSEcCtD
Bexarotene—Lethargy—Metformin—polycystic ovary syndrome	0.00484	0.0231	CcSEcCtD
Bexarotene—Migraine—Metformin—polycystic ovary syndrome	0.00466	0.0223	CcSEcCtD
Bexarotene—Dehydration—Metformin—polycystic ovary syndrome	0.00441	0.0211	CcSEcCtD
Bexarotene—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00437	0.0209	CcSEcCtD
Bexarotene—Abdominal distension—Metformin—polycystic ovary syndrome	0.00412	0.0197	CcSEcCtD
Bexarotene—Influenza—Metformin—polycystic ovary syndrome	0.0041	0.0196	CcSEcCtD
Bexarotene—Pancreatitis—Metformin—polycystic ovary syndrome	0.00402	0.0192	CcSEcCtD
Bexarotene—Angina pectoris—Metformin—polycystic ovary syndrome	0.00399	0.0191	CcSEcCtD
Bexarotene—Neutropenia—Metformin—polycystic ovary syndrome	0.00383	0.0183	CcSEcCtD
Bexarotene—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00358	0.0171	CcSEcCtD
Bexarotene—Rhinitis—Metformin—polycystic ovary syndrome	0.00329	0.0157	CcSEcCtD
Bexarotene—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00326	0.0156	CcSEcCtD
Bexarotene—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00323	0.0154	CcSEcCtD
Bexarotene—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00322	0.0154	CcSEcCtD
Bexarotene—Eye disorder—Metformin—polycystic ovary syndrome	0.00306	0.0146	CcSEcCtD
Bexarotene—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00304	0.0145	CcSEcCtD
Bexarotene—Angiopathy—Metformin—polycystic ovary syndrome	0.00297	0.0142	CcSEcCtD
Bexarotene—Chills—Metformin—polycystic ovary syndrome	0.00294	0.0141	CcSEcCtD
Bexarotene—Malnutrition—Metformin—polycystic ovary syndrome	0.00285	0.0136	CcSEcCtD
Bexarotene—Erythema—Metformin—polycystic ovary syndrome	0.00285	0.0136	CcSEcCtD
Bexarotene—Flatulence—Metformin—polycystic ovary syndrome	0.00281	0.0134	CcSEcCtD
Bexarotene—Dysgeusia—Metformin—polycystic ovary syndrome	0.00279	0.0134	CcSEcCtD
Bexarotene—Muscle spasms—Metformin—polycystic ovary syndrome	0.00274	0.0131	CcSEcCtD
Bexarotene—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00273	0.019	CbGeAlD
Bexarotene—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00265	0.0127	CcSEcCtD
Bexarotene—Malaise—Metformin—polycystic ovary syndrome	0.00257	0.0123	CcSEcCtD
Bexarotene—Syncope—Metformin—polycystic ovary syndrome	0.00256	0.0122	CcSEcCtD
Bexarotene—Palpitations—Metformin—polycystic ovary syndrome	0.00252	0.012	CcSEcCtD
Bexarotene—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00251	0.012	CcSEcCtD
Bexarotene—Hypertension—Metformin—polycystic ovary syndrome	0.00246	0.0118	CcSEcCtD
Bexarotene—Chest pain—Metformin—polycystic ovary syndrome	0.00243	0.0116	CcSEcCtD
Bexarotene—Myalgia—Metformin—polycystic ovary syndrome	0.00243	0.0116	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00241	0.0115	CcSEcCtD
Bexarotene—Discomfort—Metformin—polycystic ovary syndrome	0.0024	0.0115	CcSEcCtD
Bexarotene—Oedema—Metformin—polycystic ovary syndrome	0.00233	0.0111	CcSEcCtD
Bexarotene—Infection—Metformin—polycystic ovary syndrome	0.00231	0.0111	CcSEcCtD
Bexarotene—Shock—Metformin—polycystic ovary syndrome	0.00229	0.0109	CcSEcCtD
Bexarotene—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00228	0.0109	CcSEcCtD
Bexarotene—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00228	0.0109	CcSEcCtD
Bexarotene—Skin disorder—Metformin—polycystic ovary syndrome	0.00226	0.0108	CcSEcCtD
Bexarotene—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00225	0.0108	CcSEcCtD
Bexarotene—Anorexia—Metformin—polycystic ovary syndrome	0.00222	0.0106	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00212	0.0101	CcSEcCtD
Bexarotene—Paraesthesia—Metformin—polycystic ovary syndrome	0.00209	0.00999	CcSEcCtD
Bexarotene—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00208	0.0145	CbGeAlD
Bexarotene—Dyspnoea—Metformin—polycystic ovary syndrome	0.00208	0.00992	CcSEcCtD
Bexarotene—Somnolence—Metformin—polycystic ovary syndrome	0.00207	0.00989	CcSEcCtD
Bexarotene—Dyspepsia—Metformin—polycystic ovary syndrome	0.00205	0.0098	CcSEcCtD
Bexarotene—Decreased appetite—Metformin—polycystic ovary syndrome	0.00202	0.00967	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00201	0.00961	CcSEcCtD
Bexarotene—Fatigue—Metformin—polycystic ovary syndrome	0.00201	0.00959	CcSEcCtD
Bexarotene—Constipation—Metformin—polycystic ovary syndrome	0.00199	0.00952	CcSEcCtD
Bexarotene—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00192	0.00917	CcSEcCtD
Bexarotene—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0019	0.0091	CcSEcCtD
Bexarotene—Abdominal pain—Metformin—polycystic ovary syndrome	0.00184	0.0088	CcSEcCtD
Bexarotene—Asthenia—Metformin—polycystic ovary syndrome	0.00167	0.00798	CcSEcCtD
Bexarotene—Pruritus—Metformin—polycystic ovary syndrome	0.00165	0.00787	CcSEcCtD
Bexarotene—Diarrhoea—Metformin—polycystic ovary syndrome	0.00159	0.00761	CcSEcCtD
Bexarotene—Dizziness—Metformin—polycystic ovary syndrome	0.00154	0.00736	CcSEcCtD
Bexarotene—Vomiting—Metformin—polycystic ovary syndrome	0.00148	0.00708	CcSEcCtD
Bexarotene—Rash—Metformin—polycystic ovary syndrome	0.00147	0.00702	CcSEcCtD
Bexarotene—Dermatitis—Metformin—polycystic ovary syndrome	0.00147	0.00701	CcSEcCtD
Bexarotene—Headache—Metformin—polycystic ovary syndrome	0.00146	0.00697	CcSEcCtD
Bexarotene—Nausea—Metformin—polycystic ovary syndrome	0.00138	0.00661	CcSEcCtD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—polycystic ovary syndrome	0.000668	0.00103	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000659	0.00102	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000657	0.00102	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000646	0.000998	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IRS1—polycystic ovary syndrome	0.000636	0.000983	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—polycystic ovary syndrome	0.000633	0.000979	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000633	0.000979	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SAP30L—polycystic ovary syndrome	0.000632	0.000977	CbGpPWpGaD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000625	0.000966	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—PPARG—polycystic ovary syndrome	0.000621	0.00096	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000621	0.00096	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—INS—polycystic ovary syndrome	0.000609	0.000942	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000607	0.000939	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000604	0.000934	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000597	0.000924	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000593	0.000917	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IGF1—polycystic ovary syndrome	0.000589	0.000911	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000589	0.00091	CbGpPWpGaD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000581	0.000898	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NMNAT3—polycystic ovary syndrome	0.000578	0.000893	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000576	0.000891	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000573	0.000885	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000569	0.00088	CbGpPWpGaD
Bexarotene—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000562	0.000869	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000562	0.000869	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—SERPINE1—polycystic ovary syndrome	0.000559	0.000865	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000551	0.000852	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—IL6—polycystic ovary syndrome	0.000543	0.00084	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000539	0.000833	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—TEAD2—polycystic ovary syndrome	0.000537	0.00083	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000533	0.000824	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LPCAT2—polycystic ovary syndrome	0.000528	0.000817	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SUOX—polycystic ovary syndrome	0.000528	0.000817	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—YAP1—polycystic ovary syndrome	0.000524	0.00081	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000522	0.000807	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000513	0.000794	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.0005	0.000773	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—YAP1—polycystic ovary syndrome	0.000492	0.000761	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ISYNA1—polycystic ovary syndrome	0.000491	0.000759	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—POMC—polycystic ovary syndrome	0.00049	0.000757	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00048	0.000742	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	0.000479	0.00074	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000477	0.000738	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000467	0.000722	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000466	0.00072	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000465	0.00072	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000464	0.000718	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000463	0.000716	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000462	0.000714	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000461	0.000714	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00046	0.000712	CbGpPWpGaD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00046	0.000711	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PGR—polycystic ovary syndrome	0.000457	0.000707	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000448	0.000693	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000447	0.000691	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000443	0.000685	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000435	0.000673	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000434	0.000672	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000433	0.00067	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PGR—polycystic ovary syndrome	0.00043	0.000665	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000425	0.000657	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000424	0.000656	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TEAD2—polycystic ovary syndrome	0.000418	0.000646	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKR1C2—polycystic ovary syndrome	0.000418	0.000646	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000417	0.000645	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000413	0.000639	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000408	0.00063	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000402	0.000621	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—DLG4—polycystic ovary syndrome	0.000398	0.000615	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000395	0.000611	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000394	0.00061	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000392	0.000606	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000385	0.000595	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000384	0.000594	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RPL37A—polycystic ovary syndrome	0.000383	0.000592	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000379	0.000586	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000378	0.000585	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000378	0.000584	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000375	0.000581	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000373	0.000576	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000372	0.000575	CbGpPWpGaD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00037	0.000573	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000362	0.00056	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AR—polycystic ovary syndrome	0.000356	0.00055	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00035	0.000541	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00035	0.000541	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PNPLA2—polycystic ovary syndrome	0.00035	0.000541	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000346	0.000535	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000344	0.000532	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AR—polycystic ovary syndrome	0.000334	0.000517	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SRD5A1—polycystic ovary syndrome	0.000332	0.000513	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00033	0.00051	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—STAR—polycystic ovary syndrome	0.000316	0.000489	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000316	0.000489	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000316	0.000489	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000313	0.000484	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NCOR1—polycystic ovary syndrome	0.000311	0.000481	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000308	0.000476	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000304	0.000471	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000304	0.00047	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000304	0.000469	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.0003	0.000464	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000298	0.000461	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000293	0.000454	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000293	0.000453	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NCOR1—polycystic ovary syndrome	0.000292	0.000452	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NR3C1—polycystic ovary syndrome	0.000288	0.000445	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000283	0.000437	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMMR—polycystic ovary syndrome	0.000282	0.000436	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00028	0.000433	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000278	0.00043	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000273	0.000422	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NR3C1—polycystic ovary syndrome	0.00027	0.000418	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HSD3B1—polycystic ovary syndrome	0.000269	0.000416	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000269	0.000416	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IL6—polycystic ovary syndrome	0.000266	0.000412	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000266	0.000411	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000265	0.000411	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000265	0.00041	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—YAP1—polycystic ovary syndrome	0.000257	0.000397	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000254	0.000393	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000253	0.000392	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000252	0.00039	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00025	0.000387	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LHB—polycystic ovary syndrome	0.000245	0.000379	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000245	0.000379	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—LEP—polycystic ovary syndrome	0.000245	0.000379	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000242	0.000374	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HSD3B2—polycystic ovary syndrome	0.00024	0.000371	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000232	0.000359	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000227	0.000351	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000227	0.000351	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000226	0.00035	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000226	0.000349	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PGR—polycystic ovary syndrome	0.000224	0.000347	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARG—polycystic ovary syndrome	0.000223	0.000345	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000216	0.000333	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000214	0.000331	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARG—polycystic ovary syndrome	0.000213	0.00033	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARG—polycystic ovary syndrome	0.000209	0.000324	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—INS—polycystic ovary syndrome	0.000209	0.000324	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—RRM2—polycystic ovary syndrome	0.000207	0.00032	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000206	0.000318	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000204	0.000316	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT2—polycystic ovary syndrome	0.000202	0.000313	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000201	0.000311	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000201	0.00031	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000201	0.00031	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—YAP1—polycystic ovary syndrome	0.0002	0.000309	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000198	0.000306	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000197	0.000305	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000197	0.000305	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000195	0.000301	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NAMPT—polycystic ovary syndrome	0.000192	0.000296	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000191	0.000295	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000189	0.000293	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000189	0.000292	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000188	0.000291	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000183	0.000284	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000183	0.000283	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000179	0.000277	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000179	0.000277	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000176	0.000272	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AR—polycystic ovary syndrome	0.000174	0.000269	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000167	0.000259	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000162	0.00025	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000159	0.000247	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000159	0.000245	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000156	0.000241	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000156	0.000241	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NCOR1—polycystic ovary syndrome	0.000152	0.000236	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TH—polycystic ovary syndrome	0.000152	0.000236	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00015	0.000232	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000148	0.000229	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000148	0.000228	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000142	0.00022	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR3C1—polycystic ovary syndrome	0.000141	0.000218	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000139	0.000215	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000132	0.000205	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000131	0.000202	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00013	0.000201	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00013	0.000201	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GNAS—polycystic ovary syndrome	0.000124	0.000192	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000124	0.000192	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000121	0.000187	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000121	0.000186	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NCOR1—polycystic ovary syndrome	0.000118	0.000183	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000118	0.000183	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000117	0.000181	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000112	0.000174	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—polycystic ovary syndrome	0.000109	0.000169	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000105	0.000163	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTHFR—polycystic ovary syndrome	0.000105	0.000162	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000103	0.000159	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000103	0.000159	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.0001	0.000155	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.93e-05	0.000154	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SERPINE1—polycystic ovary syndrome	9.83e-05	0.000152	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.41e-05	0.000146	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	9.16e-05	0.000142	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—polycystic ovary syndrome	9.15e-05	0.000141	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	8.95e-05	0.000138	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	8.67e-05	0.000134	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	8.62e-05	0.000133	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—polycystic ovary syndrome	8.49e-05	0.000131	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—POMC—polycystic ovary syndrome	8.37e-05	0.000129	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—INS—polycystic ovary syndrome	8.33e-05	0.000129	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.17e-05	0.000126	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	7.98e-05	0.000123	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	7.79e-05	0.00012	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	7.73e-05	0.00012	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	7.45e-05	0.000115	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	7.16e-05	0.000111	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.12e-05	0.00011	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	7.07e-05	0.000109	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.02e-05	0.000109	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	6.94e-05	0.000107	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	6.68e-05	0.000103	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	6.63e-05	0.000102	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	6.57e-05	0.000102	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.04e-05	9.34e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5.9e-05	9.13e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	5.72e-05	8.84e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TH—polycystic ovary syndrome	5.69e-05	8.79e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	5.53e-05	8.55e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.26e-05	8.14e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	5.2e-05	8.04e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.1e-05	7.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.91e-05	7.6e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.72e-05	7.3e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.66e-05	7.21e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	4.64e-05	7.18e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	4.42e-05	6.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.4e-05	6.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.33e-05	6.7e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	4.19e-05	6.48e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.91e-05	6.04e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.75e-05	5.8e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.65e-05	5.64e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.43e-05	5.3e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	3.17e-05	4.9e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	3.13e-05	4.83e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—INS—polycystic ovary syndrome	3.11e-05	4.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.06e-05	4.73e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.92e-05	4.51e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.76e-05	4.28e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.58e-05	3.99e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.09e-05	3.23e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.06e-05	3.19e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.05e-05	3.17e-05	CbGpPWpGaD
